This study investigated the economic aspects of sevoflurane and isoflurane anesthesia in 47 healthy women undergoing elective ambulatory surgery, as part of a randomized, prospective clinical trial.
Patient records were analyzed for anesthetic ; duration of surgery, anesthesia, and recovery room stay ; and associated charges.
Sevoflurane is shorter acting than isoflurane, but it was not associated with a shorter duration of anesthesia or surgical unit stay, or earlier hospital discharge.
Total charges associated with sevoflurane anesthesia were greater than those for isoflurane ($2641 and $2230, respectively) and primarily related to prolonged anesthesia and surgical unit stay.
A minor decrease in recovery room charges ($15) associated with earlier discharge was observed with sevoflurane (p>0.05), but the agent was not associated with lower hospital charges.
Larger trials and assessment of other patient populations may show sevoflurane to be more pharmacoeconomically advantageous than isoflurane.
Mots-clés Pascal : Sévoflurane, Anesthésique général, Evaluation, Isoflurane, Analyse coût, Analyse économique, Etude comparative, Anesthésie, Chirurgie, Ambulatoire, Economie santé, Homme, Femelle, Randomisation, Prospective, Analyse avantage coût, Durée action, Effet secondaire, Coût global, Délai hospitalisation, Fluor Composé organique, Composé volatil
Mots-clés Pascal anglais : Sevoflurane, General anesthetic, Evaluation, Isoflurane, Cost analysis, Economic analysis, Comparative study, Anesthesia, Surgery, Ambulatory, Health economy, Human, Female, Randomization, Prospective, Cost benefit analysis, Duration of action, Secondary effect, Life cycle cost, Hospitalization delay, Fluorine Organic compounds, Volatile compound
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0512075
Code Inist : 002B02B08. Création : 13/02/1998.